UPDATE: Goldman Sachs Downgrades Amylyx Pharmaceuticals inc. (AMLX) to Neutral
Tweet Send to a Friend
(Updated - April 1, 2022 4:22 AM EDT)
Goldman Sachs analyst Chris Shibutani downgraded Amylyx Pharmaceuticals inc. (NASDAQ: AMLX) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Goldman Sachs analyst Chris Shibutani downgraded Amylyx Pharmaceuticals inc. (NASDAQ: AMLX) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
